{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:35:01Z","timestamp":1781818501494,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s12185-023-03546-6","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T03:38:36Z","timestamp":1676000316000},"page":"738-747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia\/lymphoma (ALL) and non-ETP T-ALL"],"prefix":"10.1007","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0032-6994","authenticated-orcid":false,"given":"Yasushi","family":"Onishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijiro","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Fukatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kameoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Oyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuyuki","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Sukegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yanagiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriko","family":"Harazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"issue":"9617","key":"3546_CR1","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"CH Pui","year":"2008","unstructured":"Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371(9617):1030\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(08)60457-2.","journal-title":"Lancet"},{"issue":"25","key":"3546_CR2","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","volume":"114","author":"DI Marks","year":"2009","unstructured":"Marks DI, Paietta EM, Moorman AV, Richards SM, Buck G, DeWald G, et al. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993). Blood. 2009;114(25):5136\u201345. https:\/\/doi.org\/10.1182\/blood-2009-08-231217.","journal-title":"Blood"},{"issue":"2","key":"3546_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009;10(2):147\u201356. https:\/\/doi.org\/10.1016\/S1470-2045(08)70314-0.","journal-title":"Lancet Oncol"},{"issue":"3","key":"3546_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2141.2011.08955.x","volume":"156","author":"T Inukai","year":"2012","unstructured":"Inukai T, Kiyokawa N, Campana D, Coustan-Smith E, Kikuchi A, Kobayashi M, et al. Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children\u2019s Cancer Study Group Study L99\u201315. Br J Haematol. 2012;156(3):358\u201365. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08955.x.","journal-title":"Br J Haematol"},{"issue":"4","key":"3546_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s11684-012-0224-4","volume":"6","author":"M Ma","year":"2012","unstructured":"Ma M, Wang X, Tang J, Xue H, Chen J, Pan C, et al. Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia. Front Med. 2012;6(4):416\u201320. https:\/\/doi.org\/10.1007\/s11684-012-0224-4.","journal-title":"Front Med"},{"issue":"3","key":"3546_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/bjh.12882","volume":"166","author":"K Patrick","year":"2014","unstructured":"Patrick K, Wade R, Goulden N, Mitchell C, Moorman AV, Rowntree C, et al. Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. Br J Haematol. 2014;166(3):421\u20134. https:\/\/doi.org\/10.1111\/bjh.12882.","journal-title":"Br J Haematol"},{"issue":"1","key":"3546_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/bjh.15503","volume":"183","author":"S Fuhrmann","year":"2018","unstructured":"Fuhrmann S, Schabath R, Moricke A, Zimmermann M, Kunz JB, Kulozik AE, et al. Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial. Br J Haematol. 2018;183(1):96\u2013103. https:\/\/doi.org\/10.1111\/bjh.15503.","journal-title":"Br J Haematol"},{"issue":"1","key":"3546_CR8","doi-asserted-by":"publisher","first-page":"e28719","DOI":"10.1002\/pbc.28719","volume":"68","author":"MA Burns","year":"2021","unstructured":"Burns MA, Place AE, Stevenson KE, Gutierrez A, Forrest S, Pikman Y, et al. Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001. Pediatr Blood Cancer. 2021;68(1):e28719. https:\/\/doi.org\/10.1002\/pbc.28719.","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"3546_CR9","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1007\/s00432-021-03551-4","volume":"147","author":"X Liu","year":"2021","unstructured":"Liu X, Zou Y, Zhang L, Chen X, Yang W, Guo Y, et al. Early T-cell precursor acute lymphoblastic leukemia and other subtypes: a retrospective case report from a single pediatric center in China. J Cancer Res Clin Oncol. 2021;147(9):2775\u201388. https:\/\/doi.org\/10.1007\/s00432-021-03551-4.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"3546_CR10","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1038\/bcj.2011.49","volume":"2","author":"M Neumann","year":"2012","unstructured":"Neumann M, Heesch S, Gokbuget N, Schwartz S, Schlee C, Benlasfer O, et al. Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer J. 2012;2(1):e55. https:\/\/doi.org\/10.1038\/bcj.2011.49.","journal-title":"Blood Cancer J"},{"issue":"15","key":"3546_CR11","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","volume":"127","author":"N Jain","year":"2016","unstructured":"Jain N, Lamb AV, O\u2019Brien S, Ravandi F, Konopleva M, Jabbour E, et al. Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype. Blood. 2016;127(15):1863\u20139. https:\/\/doi.org\/10.1182\/blood-2015-08-661702.","journal-title":"Blood"},{"issue":"23","key":"3546_CR12","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1200\/JCO.2016.71.8585","volume":"35","author":"J Bond","year":"2017","unstructured":"Bond J, Graux C, Lhermitte L, Lara D, Cluzeau T, Leguay T, et al. Early response-based therapy stratification improves survival in adult early thymic precursor acute lymphoblastic leukemia: a group for research on adult acute lymphoblastic leukemia study. J Clin Oncol. 2017;35(23):2683\u201391. https:\/\/doi.org\/10.1200\/JCO.2016.71.8585.","journal-title":"J Clin Oncol"},{"key":"3546_CR13","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3389\/fonc.2020.01423","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Qian JJ, Zhou YL, Huang X, Li JH, Li XY, et al. Comparison of early T-cell precursor and Non-ETP subtypes among 122 Chinese adults with acute lymphoblastic leukemia. Front Oncol. 2020;10:1423. https:\/\/doi.org\/10.3389\/fonc.2020.01423.","journal-title":"Front Oncol"},{"issue":"2","key":"3546_CR14","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/S2352-3026(15)00254-9","volume":"3","author":"V Conter","year":"2016","unstructured":"Conter V, Valsecchi MG, Buldini B, Parasole R, Locatelli F, Colombini A, et al. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis. Lancet Haematol. 2016;3(2):e80\u20136. https:\/\/doi.org\/10.1016\/S2352-3026(15)00254-9.","journal-title":"Lancet Haematol"},{"issue":"5","key":"3546_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ajh.26144","volume":"96","author":"K Morita","year":"2021","unstructured":"Morita K, Jain N, Kantarjian H, Takahashi K, Fang H, Konopleva M, et al. Outcome of T-cell acute lymphoblastic leukemia\/lymphoma: focus on near-ETP phenotype and differential impact of nelarabine. Am J Hematol. 2021;96(5):589\u201398. https:\/\/doi.org\/10.1002\/ajh.26144.","journal-title":"Am J Hematol"},{"issue":"3","key":"3546_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s12185-010-0672-z","volume":"92","author":"I Jinnai","year":"2010","unstructured":"Jinnai I, Sakura T, Tsuzuki M, Maeda Y, Usui N, Kato M, et al. Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study. Int J Hematol. 2010;92(3):490\u2013502. https:\/\/doi.org\/10.1007\/s12185-010-0672-z.","journal-title":"Int J Hematol"},{"key":"3546_CR17","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1038\/bcj.2014.72","volume":"4","author":"F Hayakawa","year":"2014","unstructured":"Hayakawa F, Sakura T, Yujiri T, Kondo E, Fujimaki K, Sasaki O, et al. Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group. Blood Cancer J. 2014;4:e252. https:\/\/doi.org\/10.1038\/bcj.2014.72.","journal-title":"Blood Cancer J"},{"issue":"3","key":"3546_CR18","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/leu.2017.283","volume":"32","author":"T Sakura","year":"2018","unstructured":"Sakura T, Hayakawa F, Sugiura I, Murayama T, Imai K, Usui N, et al. High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG. Leukemia. 2018;32(3):626\u201332. https:\/\/doi.org\/10.1038\/leu.2017.283.","journal-title":"Leukemia"},{"issue":"6","key":"3546_CR19","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15(6):825\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"3546_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69(2):204\u201317.","journal-title":"Am J Med"},{"issue":"3","key":"3546_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48(3):452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3546_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/ajh.26069","volume":"96","author":"HP Wang","year":"2021","unstructured":"Wang HP, Zhou YL, Huang X, Zhang Y, Qian JJ, Li JH, et al. CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia. Am J Hematol. 2021;96(3):312\u20139. https:\/\/doi.org\/10.1002\/ajh.26069.","journal-title":"Am J Hematol"},{"key":"3546_CR23","doi-asserted-by":"publisher","first-page":"846573","DOI":"10.3389\/fonc.2022.846573","volume":"12","author":"J Xiao","year":"2022","unstructured":"Xiao J, Cai Z, Wang H, Li X, Zhou B, Liu Y, et al. The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL\/LBL: A Real-World Multicenter Study in China. Front Oncol. 2022;12:846573. https:\/\/doi.org\/10.3389\/fonc.2022.846573.","journal-title":"Front Oncol"},{"key":"3546_CR24","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00127","author":"Y Numan","year":"2018","unstructured":"Numan Y, Alfayez M, Maiti A, Alvarado Y, Jabbour EJ, Ferrajoli A, et al. First report of clinical response to Venetoclax in early T-cell precursor acute lymphoblastic leukemia. JCO Precis Oncol. 2018. https:\/\/doi.org\/10.1200\/PO.18.00127.","journal-title":"JCO Precis Oncol"},{"key":"3546_CR25","doi-asserted-by":"publisher","first-page":"6092646","DOI":"10.1155\/2018\/6092646","volume":"2018","author":"LT Rahmat","year":"2018","unstructured":"Rahmat LT, Nguyen A, Abdulhaq H, Prakash S, Logan AC, Mannis GN. Venetoclax in combination with decitabine for relapsed T-cell acute lymphoblastic leukemia after allogeneic hematopoietic cell transplant. Case Rep Hematol. 2018;2018:6092646. https:\/\/doi.org\/10.1155\/2018\/6092646.","journal-title":"Case Rep Hematol"},{"key":"3546_CR26","doi-asserted-by":"publisher","DOI":"10.1200\/PO.19.00172","author":"R La Starza","year":"2019","unstructured":"La Starza R, Cambo B, Pierini A, Bornhauser B, Montanaro A, Bourquin JP, et al. Venetoclax and bortezomib in relapsed\/refractory early T-cell precursor acute lymphoblastic leukemia. JCO Precis Oncol. 2019. https:\/\/doi.org\/10.1200\/PO.19.00172.","journal-title":"JCO Precis Oncol"},{"issue":"7380","key":"3546_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481(7380):157\u201363. https:\/\/doi.org\/10.1038\/nature10725.","journal-title":"Nature"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03546-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03546-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03546-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T13:22:47Z","timestamp":1682083367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03546-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["3546"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03546-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"assertion":[{"value":"7 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}